AMCA
Arthur M. Cohen & Associates’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,564
| Closed | -$227K | – | 136 |
|
|
2023
Q4 | $227K | Sell |
10,564
-2,377
| -18% | -$51K | 0.05% | 123 |
|
|
2023
Q3 | $267K | Sell |
12,941
-8,189
| -39% | -$169K | 0.07% | 110 |
|
|
2023
Q2 | $624K | Buy |
21,130
+3,651
| +21% | +$108K | 0.15% | 72 |
|
|
2023
Q1 | $403K | Buy |
17,479
+2,141
| +14% | +$49.3K | 0.11% | 88 |
|
|
2022
Q4 | $427K | Hold |
15,338
| – | – | 0.12% | 91 |
|
|
2022
Q3 | $471K | Buy |
15,338
+2,922
| +24% | +$89.7K | 0.13% | 84 |
|
|
2022
Q2 | $365K | Hold |
12,416
| – | – | 0.09% | 98 |
|
|
2022
Q1 | $399K | Hold |
12,416
| – | – | 0.08% | 98 |
|
|
2021
Q4 | $554K | Buy |
12,416
+4,869
| +65% | +$217K | 0.1% | 98 |
|
|
2021
Q3 | $381K | Buy |
7,547
+4,139
| +121% | +$209K | 0.08% | 114 |
|
|
2021
Q2 | $267K | Buy |
+3,408
| New | +$267K | 0.05% | 130 |
|